Sirona's
US$ 20.88
intranasal glutathione in parkinson's disease and Reported indications for use of
Description
After 4 weeks, behavioral, biochemical, and immunohistochemical tests were performed (Cassano and Magini 2019)
Surprisingly, this effect was not reproduced by the ER agonist, PPT (150)
All of the patients who were treated orally corrected their vitamin B12 levels and at least two-thirds corrected their hematological abnormalities
Infect Diseas Poverty
10.1186/1423-0127-17-S1-S23 J
